Needham analyst Michael Matson assigned a Buy rating to OncoCyte (OCX) today and set a price target of $8.00.
The post Needham Assigns a Buy Rating on OncoCyte (OCX) appeared first on Smarter Analyst.
Needham analyst Michael Matson assigned a Buy rating to OncoCyte (OCX) today and set a price target...

https://www.smarteranalyst.com/new-blurbs/needham-assigns-a-buy-rating-on-oncocyte-ocx-3/

#SmarterAnalyst